Foghorn Therapeutics Inc. banner

Foghorn Therapeutics Inc.
NASDAQ:FHTX

Watchlist Manager
Foghorn Therapeutics Inc. Logo
Foghorn Therapeutics Inc.
NASDAQ:FHTX
Watchlist
Price: 4.88 USD -3.56% Market Closed
Market Cap: $285.8m

During the last 3 months Foghorn Therapeutics Inc. insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 7% over this period (open performance analysis).

The last transaction was made on Sep 23, 2024 by Costa Carlos , who sold 8.7k USD worth of FHTX shares.

Last Transactions:
Costa Carlos
$-8.7k
Costa Carlos
$-359k
Costa Carlos
$-116.3k
Costa Carlos
$-103.1k
Costa Carlos
$-4k
Bellon Steven F.
$-190k
Afeyan Noubar
$+10m
Cavalie Fanny
$-72.1k
Agresta Samuel
$-2.6m
Decicco Carl
$+88k
Abu Dhabi Investment Authority
$+2.4m
Flagship Ventures Fund V General Partner Llc
$+800k
View All Transactions

During the last 3 months Foghorn Therapeutics Inc. insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 7% over this period (open performance analysis).

The last transaction was made on Sep 23, 2024 by Costa Carlos , who sold 8.7k USD worth of FHTX shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Foghorn Therapeutics Inc.
Insider Trading Chart

Foghorn Therapeutics Inc.
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Foghorn Therapeutics Inc.
Last Insider Transactions

Global
Insiders Monitor

Foghorn Therapeutics Inc.
Glance View

Market Cap
285.8m USD
Industry
Biotechnology

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 119 full-time employees. The company went IPO on 2020-10-23. The firm's Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is initially focused on oncology. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, which is evaluating in separate Phase I studies in metastatic uveal melanoma and relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The company is also developing FHD-609, a protein degrader, to treat synovial sarcoma is in phase I study. The firm is also engaged in developing additional programs targeting populations that include selective BRM and selective ARID1B modulators. Foghorn Securities Corporation is its subsidiary.

FHTX Intrinsic Value
3.73 USD
Overvaluation 24%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett